日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs

患有狭窄型或穿透型克罗恩病表型的患者报告疾病负担重，治疗需求高

期刊:Inflammatory Bowel Diseases
影响因子:4.3
doi:10.1093/ibd/izac162
Fan, Yanni; Zhang, Ling; Omidakhsh, Negar; Bohn, Rhonda L; Thompson, Jennifer S; Brodovicz, Kimberly G; Deepak, Parakkal
克罗恩病
发表日期：2023
文献求助 收藏

Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

恩格列净在常规护理患者中的有效性和安全性：恩格列净比较有效性和安全性（EMPRISE）研究的结果

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14593
Patorno, Elisabetta; Pawar, Ajinkya; Wexler, Deborah J; Glynn, Robert J; Bessette, Lily G; Paik, Julie M; Najafzadeh, Mehdi; Brodovicz, Kimberly G; Déruaz-Luyet, Anouk; Schneeweiss, Sebastian
发表日期：2022
文献求助 收藏

Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study

恩格列净在东亚常规治疗中的心血管和肾脏疗效：EMPRISE 东亚研究的结果

期刊:Endocrinology, Diabetes and Metabolism
影响因子:2.6
doi:10.1002/edm2.183
Seino, Yutaka; Kim, Dae Jung; Yabe, Daisuke; Tan, Elise Chia-Hui; Chung, Wook-Jin; Ha, Kyoung Hwa; Nangaku, Masaomi; Node, Koichi; Klement, Riho; Yasui, Atsutaka; Lei, Wei-Yu; Lee, Sunwoo; Kyaw, Moe H; Deruaz-Luyet, Anouk; Brodovicz, Kimberly G; H-H Sheu, Wayne
发表日期：2021
文献求助 收藏

Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure

按eGFR分期划分的糖尿病、心血管疾病和心力衰竭患者及非糖尿病、心血管疾病和心力衰竭患者的医疗保健支出类型

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.2019121308
Nichols, Gregory A; Ustyugova, Anastasia; Déruaz-Luyet, Anouk; O'Keeffe-Rosetti, Maureen; Brodovicz, Kimberly G
心血管疾病
心血管
代谢
糖尿病
心力衰竭
发表日期：2020
文献求助 收藏

Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014

2010年至2014年美国1型和2型糖尿病患者下肢截肢发生率

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14012
Déruaz-Luyet, Anouk; Raabe, Christina; Garry, Elizabeth M; Brodovicz, Kimberly G; Lavery, Lawrence A
糖尿病
代谢
发表日期：2020
文献求助 收藏

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care

恩格列净疗效和安全性比较研究 (EMPRISE) 项目：评估恩格列净在常规临床护理中的应用的设计和暴露量累积

期刊:Endocrinology, Diabetes and Metabolism
影响因子:2.6
doi:10.1002/edm2.103
Patorno, Elisabetta; Najafzadeh, Mehdi; Pawar, Ajinkya; Franklin, Jessica M; Déruaz-Luyet, Anouk; Brodovicz, Kimberly G; Santiago Ortiz, Adrian J; Bessette, Lily G; Kulldorff, Martin; Schneeweiss, Sebastian
发表日期：2020
文献求助 收藏

Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes

2型糖尿病患者与非2型糖尿病患者中，不同估算肾小球滤过率和蛋白尿水平组的肾脏疾病进展和全因死亡率

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-020-01792-y
Nichols, Gregory A; Déruaz-Luyet, Anouk; Brodovicz, Kimberly G; Kimes, Teresa M; Rosales, A Gabriela; Hauske, Sibylle J
糖尿病
代谢
发表日期：2020
文献求助 收藏

Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes

更正：2 型糖尿病患者与非 2 型糖尿病患者中，不同估算肾小球滤过率和蛋白尿水平类别与肾脏疾病进展和全因死亡率的关系

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-020-01854-1
Nichols, Gregory A; Déruaz-Luyet, Anouk; Brodovicz, Kimberly G; Kimes, Teresa M; Rosales, A Gabriela; Hauske, Sibylle J
糖尿病
代谢
发表日期：2020
文献求助 收藏

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care

恩格列净与常规临床护理中心力衰竭住院风险

期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.118.039177
Patorno, Elisabetta; Pawar, Ajinkya; Franklin, Jessica M; Najafzadeh, Mehdi; Déruaz-Luyet, Anouk; Brodovicz, Kimberly G; Sambevski, Steven; Bessette, Lily G; Santiago Ortiz, Adrian J; Kulldorff, Martin; Schneeweiss, Sebastian
心力衰竭
心血管
发表日期：2019
文献求助 收藏

Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care

在2型糖尿病患者中，利格列汀与其他口服降糖药相比的心血管安全性：一项常规护理中的序贯监测方案

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.13735
Patorno, Elisabetta; Gopalakrishnan, Chandrasekar; Brodovicz, Kimberly G; Meyers, Andrea; Bartels, Dorothee B; Liu, Jun; Kulldorff, Martin; Schneeweiss, Sebastian
糖尿病
代谢
发表日期：2019
文献求助 收藏